Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Rafael G. dos Santos(Clinics Hospital of Ribeirão Preto), Jaime E. C. Hallak(Universidade de Ribeirão Preto), Flávia de Lima Osório(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Jordi Riba(Universitat Autònoma de Barcelona), José Alexandre S. Crippa(Universidade de Ribeirão Preto), Antônio Waldo Zuardi(Universidade de Ribeirão Preto)
Cited by 303
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465